Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 153

1.

Low dose chloroquine decreases insulin resistance in human metabolic syndrome but does not reduce carotid intima-media thickness.

McGill JB, Johnson M, Hurst S, Cade WT, Yarasheski KE, Ostlund RE, Schechtman KB, Razani B, Kastan MB, McClain DA, de Las Fuentes L, Davila-Roman VG, Ory DS, Wickline SA, Semenkovich CF.

Diabetol Metab Syndr. 2019 Jul 29;11:61. doi: 10.1186/s13098-019-0456-4. eCollection 2019.

2.

Biologic and social factors predict incident kidney disease in type 1 diabetes: Results from the T1D exchange clinic network.

McGill JB, Wu M, Pop-Busui R, Mizokami-Stout K, Tamborlane WV, Aleppo G, Gubitosi-Klug RA, Haller MJ, Willi SM, Foster NC, Zimmerman C, Libman I, Polsky S, Rickels MR.

J Diabetes Complications. 2019 Jun 26. pii: S1056-8727(19)30391-5. doi: 10.1016/j.jdiacomp.2019.06.005. [Epub ahead of print]

PMID:
31279735
3.

Preventing Early Renal Loss in Diabetes (PERL) Study: A Randomized Double-Blinded Trial of Allopurinol-Rationale, Design, and Baseline Data.

Afkarian M, Polsky S, Parsa A, Aronson R, Caramori ML, Cherney DZ, Crandall JP, de Boer IH, Elliott TG, Galecki AT, Goldfine AB, Haw JS, Hirsch IB, Karger AB, Lingvay I, Maahs DM, McGill JB, Molitch ME, Perkins BA, Pop-Busui R, Pragnell M, Rosas SE, Rossing P, Senior P, Sigal RJ, Spino C, Tuttle KR, Umpierrez GE, Wallia A, Weinstock RS, Wu C, Mauer M, Doria A; PERL Study Group.

Diabetes Care. 2019 Aug;42(8):1454-1463. doi: 10.2337/dc19-0342. Epub 2019 Jun 11.

PMID:
31186299
4.

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2019 EXECUTIVE SUMMARY.

Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, DeFronzo RA, Einhorn D, Fonseca VA, Garber JR, Garvey WT, Grunberger G, Handelsman Y, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez GE.

Endocr Pract. 2019 Jan;25(1):69-100. doi: 10.4158/CS-2018-0535. Erratum in: Endocr Pract. 2019 Feb;25(2):204.

PMID:
30742570
5.

Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease.

Charytan DM, Solomon SD, Ivanovich P, Remuzzi G, Cooper ME, McGill JB, Parving HH, Parfrey P, Singh AK, Burdmann EA, Levey AS, Eckardt KU, McMurray JJV, Weinrauch LA, Liu J, Claggett B, Lewis EF, Pfeffer MA.

Diabetes Obes Metab. 2019 May;21(5):1199-1208. doi: 10.1111/dom.13642. Epub 2019 Mar 4.

PMID:
30672083
6.

Treatment of Anemia With Darbepoetin Prior to Dialysis Initiation and Clinical Outcomes: Analyses From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).

Mc Causland FR, Claggett B, Burdmann EA, Chertow GM, Cooper ME, Eckardt KU, Ivanovich P, Levey AS, Lewis EF, McGill JB, McMurray JJV, Parfrey P, Parving HH, Remuzzi G, Singh AK, Solomon SD, Toto RD, Pfeffer MA.

Am J Kidney Dis. 2019 Mar;73(3):309-315. doi: 10.1053/j.ajkd.2018.10.006. Epub 2018 Dec 19.

PMID:
30578152
7.

Analysis of novel domain-specific mutations in the zebrafish ndr2/cyclops gene generated using CRISPR-Cas9 RNPs.

Turner AN, Andersen RS, Bookout IE, Brashear LN, Davis JC, Gahan DM, Davis JC, Gotham JP, Hijaz BA, Kaushik AS, Mcgill JB, Miller VL, Moseley ZP, Nowell CL, Patel RK, Rodgers MC, Patel RK, Shihab YA, Walker AP, Glover SR, Foster SD, Challa AK.

J Genet. 2018 Dec;97(5):1315-1325.

8.

CHEIROARTHROPATHY: A COMMON DISORDER IN PATIENTS IN THE T1D EXCHANGE.

Aleppo G, Kanapka LG, Foster NC, Wu M, Clements MA, Rickels MR, McGill JB, Beck RW; T1D Exchange Clinic Network.

Endocr Pract. 2019 Feb;25(2):138-143. doi: 10.4158/EP-2018-0346. Epub 2018 Nov 1.

PMID:
30383489
9.

Late-Onset T1DM and Older Age Predict Risk of Additional Autoimmune Disease.

Hughes JW, Bao YK, Salam M, Joshi P, Kilpatrick CR, Juneja K, Nieves D, Bouhairie V, Jordan OJ, Blustein EC, Tobin GS, McGill JB.

Diabetes Care. 2019 Jan;42(1):32-38. doi: 10.2337/dc18-1157. Epub 2018 Oct 25.

PMID:
30361208
10.

High prevalence of comorbid autoimmune diseases in adults with type 1 diabetes from the HealthFacts database.

Bao YK, Weide LG, Ganesan VC, Jakhar I, McGill JB, Sahil S, Cheng AL, Gaddis M, Drees BM.

J Diabetes. 2019 Apr;11(4):273-279. doi: 10.1111/1753-0407.12856. Epub 2018 Nov 4.

PMID:
30226016
11.

High prevalence of systemic rheumatic diseases in women with type 1 diabetes.

Bao YK, Salam M, Parks D, McGill JB, Hughes J.

J Diabetes Complications. 2018 Aug;32(8):737-739. doi: 10.1016/j.jdiacomp.2018.06.001. Epub 2018 Jun 7.

12.

Effect of a Shoulder Movement Intervention on Joint Mobility, Pain, and Disability in People With Diabetes: A Randomized Controlled Trial.

Mueller MJ, Sorensen CJ, McGill JB, Clark BR, Lang CE, Chen L, Bohnert KL, Hastings MK.

Phys Ther. 2018 Sep 1;98(9):745-753. doi: 10.1093/ptj/pzy070.

PMID:
29893977
13.

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2018 EXECUTIVE SUMMARY.

Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, DeFronzo RA, Einhorn D, Fonseca VA, Garber JR, Garvey WT, Grunberger G, Handelsman Y, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez GE.

Endocr Pract. 2018 Jan;24(1):91-120. doi: 10.4158/CS-2017-0153. Epub 2018 Jan 17.

PMID:
29368965
14.

HIGH-RISK GASTRIC PATHOLOGY AND PREVALENT AUTOIMMUNE DISEASES IN PATIENTS WITH PERNICIOUS ANEMIA.

Hughes JW, Muegge BD, Tobin GS, Litvin M, Sun L, Saenz JB, Gyawali CP, McGill JB.

Endocr Pract. 2017 Nov;23(11):1297-1303. doi: 10.4158/EP-2017-0056.

PMID:
29190137
15.

Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections: A Randomized Trial.

Beck RW, Riddlesworth TD, Ruedy K, Ahmann A, Haller S, Kruger D, McGill JB, Polonsky W, Price D, Aronoff S, Aronson R, Toschi E, Kollman C, Bergenstal R; DIAMOND Study Group.

Ann Intern Med. 2017 Sep 19;167(6):365-374. doi: 10.7326/M16-2855. Epub 2017 Aug 22.

PMID:
28828487
16.

Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial.

Beck RW, Riddlesworth TD, Ruedy KJ, Kollman C, Ahmann AJ, Bergenstal RM, Bhargava A, Bode BW, Haller S, Kruger DF, McGill JB, Polonsky W, Price D, Toschi E; DIAMOND Study Group.

Lancet Diabetes Endocrinol. 2017 Sep;5(9):700-708. doi: 10.1016/S2213-8587(17)30217-6. Epub 2017 Jul 12.

PMID:
28711468
17.

ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD.

Charytan DM, Solomon SD, Ivanovich P, Remuzzi G, Cooper ME, McGill JB, Parving HH, Parfrey P, Singh AK, Burdmann EA, Levey AS, de Zeeuw D, Eckardt KU, McMurray JJV, Claggett B, Lewis EF, Pfeffer MA.

Am J Kidney Dis. 2017 Oct;70(4):522-531. doi: 10.1053/j.ajkd.2017.04.018. Epub 2017 Jun 7.

PMID:
28599901
18.

Continuous Glucose Monitoring with Multiple Daily Insulin Treatment: Outcome Studies.

McGill JB, Ahmann A.

Diabetes Technol Ther. 2017 Jun;19(S3):S3-S12. doi: 10.1089/dia.2017.0090. Review.

19.

Relationship of shoulder activity and skin intrinsic fluorescence with low level shoulder pain and disability in people with type 2 diabetes.

Sorensen CJ, Hastings MK, Lang CE, McGill JB, Clark BR, Bohnert KL, Mueller MJ.

J Diabetes Complications. 2017 Jun;31(6):983-987. doi: 10.1016/j.jdiacomp.2017.03.005. Epub 2017 Mar 18.

20.

Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.

Beck RW, Riddlesworth T, Ruedy K, Ahmann A, Bergenstal R, Haller S, Kollman C, Kruger D, McGill JB, Polonsky W, Toschi E, Wolpert H, Price D; DIAMOND Study Group.

JAMA. 2017 Jan 24;317(4):371-378. doi: 10.1001/jama.2016.19975.

PMID:
28118453
21.

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2017 EXECUTIVE SUMMARY.

Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, DeFronzo RA, Einhorn D, Fonseca VA, Garber JR, Garvey WT, Grunberger G, Handelsman Y, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez GE.

Endocr Pract. 2017 Feb;23(2):207-238. doi: 10.4158/EP161682.CS. Epub 2017 Jan 17.

PMID:
28095040
22.

Autoimmune Diseases in Children and Adults With Type 1 Diabetes From the T1D Exchange Clinic Registry.

Hughes JW, Riddlesworth TD, DiMeglio LA, Miller KM, Rickels MR, McGill JB; T1D Exchange Clinic Network.

J Clin Endocrinol Metab. 2016 Dec;101(12):4931-4937. Epub 2016 Sep 27.

PMID:
27676394
23.

Moyamoya syndrome causing stroke in young women with type 1 diabetes.

Hughes JW, Wyckoff JA, Hollander AS, Derdeyn CP, McGill JB.

J Diabetes Complications. 2016 Nov - Dec;30(8):1640-1642. doi: 10.1016/j.jdiacomp.2016.08.004. Epub 2016 Aug 12.

24.

Diabetic Kidney Disease.

Bouhairie VE, McGill JB.

Mo Med. 2016 Sep-Oct;113(5):390-394.

25.

Making Insulin Accessible: Does Inhaled Insulin Fill an Unmet Need?

McGill JB, Ahn D, Edelman SV, Kilpatrick CR, Santos Cavaiola T.

Adv Ther. 2016 Aug;33(8):1267-78. doi: 10.1007/s12325-016-0370-1. Epub 2016 Jul 6. Review.

PMID:
27384191
26.

'SeXX' matters: In the myocardium of patients with type 1 diabetes.

Mikhalkova D, McGill JB, Peterson LR.

J Nucl Cardiol. 2016 Oct;23(5):970-972. doi: 10.1007/s12350-016-0507-2. Epub 2016 Jun 14. No abstract available.

PMID:
27301960
27.

Strategies for glucose control in a study population with diabetes, renal disease and anemia (Treat study).

Weinrauch LA, D'Elia JA, Finn P, Lewis EF, Desai AS, Claggett BL, Cooper ME, McGill JB.

Diabetes Res Clin Pract. 2016 Mar;113:143-51. doi: 10.1016/j.diabres.2015.12.021. Epub 2016 Jan 18.

PMID:
26830074
28.

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2016 EXECUTIVE SUMMARY.

Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, DeFronzo RA, Einhorn D, Fonseca VA, Garber JR, Garvey WT, Grunberger G, Handelsman Y, Henry RR, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez GE; American Association of Clinical Endocrinologists (AACE); American College of Endocrinology (ACE).

Endocr Pract. 2016 Jan;22(1):84-113. doi: 10.4158/EP151126.CS. No abstract available.

PMID:
26731084
29.

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2015 EXECUTIVE SUMMARY.

Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, Davidson MB, Einhorn D, Garber JR, Garvey WT, Grunberger G, Handelsman Y, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez GE; American Association of Clinical Endocrinologists (AACE); American College of Endocrinology (ACE).

Endocr Pract. 2015 Dec;21(12):1403-14. doi: 10.4158/EP151063.CS.

PMID:
26642101
30.

Inhaled Technosphere Insulin Versus Inhaled Technosphere Placebo in Insulin-Naïve Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetes Agents.

Rosenstock J, Franco D, Korpachev V, Shumel B, Ma Y, Baughman R, Amin N, McGill JB; Affinity 2 Study Group.

Diabetes Care. 2015 Dec;38(12):2274-81. doi: 10.2337/dc15-0629. Epub 2015 Aug 7.

PMID:
26253730
31.

MAXIMIZING PATIENT SAFETY WITH NEWLY APPROVED THERAPIES: FOCUS ON SGLT2 INHIBITORS.

McGill JB.

Endocr Pract. 2015 Sep;21(9):1076-8. doi: 10.4158/EP15849.CO. Epub 2015 Jul 27. No abstract available.

PMID:
26214109
32.

Inhaled Technosphere Insulin Compared With Injected Prandial Insulin in Type 1 Diabetes: A Randomized 24-Week Trial.

Bode BW, McGill JB, Lorber DL, Gross JL, Chang PC, Bregman DB; Affinity 1 Study Group.

Diabetes Care. 2015 Dec;38(12):2266-73. doi: 10.2337/dc15-0075. Epub 2015 Jul 15.

PMID:
26180109
33.

PITUITARY DYSFUNCTION IN DEVELOPMENTAL DELAY: MEDICAL AND ETHICAL CONCERNS.

McGill JB, Silverstein JM, Wren ME.

Endocr Pract. 2015 Jul;21(7):848-50. doi: 10.4158/EP14424.CO. Epub 2015 Jun 29. No abstract available.

PMID:
26121462
34.

Kidney Disease End Points in a Pooled Analysis of Individual Patient-Level Data From a Large Clinical Trials Program of the Dipeptidyl Peptidase 4 Inhibitor Linagliptin in Type 2 Diabetes.

Cooper ME, Perkovic V, McGill JB, Groop PH, Wanner C, Rosenstock J, Hehnke U, Woerle HJ, von Eynatten M.

Am J Kidney Dis. 2015 Sep;66(3):441-9. doi: 10.1053/j.ajkd.2015.03.024. Epub 2015 May 7.

35.

Combination of the dipeptidyl peptidase-4 inhibitor linagliptin with insulin-based regimens in type 2 diabetes and chronic kidney disease.

McGill JB, Yki-Järvinen H, Crowe S, Woerle HJ, von Eynatten M.

Diab Vasc Dis Res. 2015 Jul;12(4):249-57. doi: 10.1177/1479164115579001. Epub 2015 May 4.

PMID:
25941160
36.

Type 2 diabetes, obesity, and sex difference affect the fate of glucose in the human heart.

Peterson LR, Herrero P, Coggan AR, Kisrieva-Ware Z, Saeed I, Dence C, Koudelis D, McGill JB, Lyons MR, Novak E, Dávila-Román VG, Waggoner AD, Gropler RJ.

Am J Physiol Heart Circ Physiol. 2015 Jun 15;308(12):H1510-6. doi: 10.1152/ajpheart.00722.2014. Epub 2015 Apr 17.

37.

AACE/ACE comprehensive diabetes management algorithm 2015.

Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, Davidson MB, Einhorn D, Garber JR, Garvey WT, Grunberger G, Handelsman Y, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez G, Davidson MH.

Endocr Pract. 2015 Apr;21(4):438-47. doi: 10.4158/EP15693.CS. Epub 2015 Apr 15. No abstract available.

PMID:
25877012
38.

American association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015.

Handelsman Y, Bloomgarden ZT, Grunberger G, Umpierrez G, Zimmerman RS, Bailey TS, Blonde L, Bray GA, Cohen AJ, Dagogo-Jack S, Davidson JA, Einhorn D, Ganda OP, Garber AJ, Garvey WT, Henry RR, Hirsch IB, Horton ES, Hurley DL, Jellinger PS, Jovanovič L, Lebovitz HE, LeRoith D, Levy P, McGill JB, Mechanick JI, Mestman JH, Moghissi ES, Orzeck EA, Pessah-Pollack R, Rosenblit PD, Vinik AI, Wyne K, Zangeneh F.

Endocr Pract. 2015 Apr;21 Suppl 1:1-87. doi: 10.4158/EP15672.GL. No abstract available.

39.

Relationship Between Skin Intrinsic Fluorescence--an Indicator of Advanced Glycation End Products-and Upper Extremity Impairments in Individuals With Diabetes Mellitus.

Shah KM, Clark BR, McGill JB, Lang CE, Maynard J, Mueller MJ.

Phys Ther. 2015 Aug;95(8):1111-9. doi: 10.2522/ptj.20140340. Epub 2015 Apr 9.

40.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY--CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN--2015--EXECUTIVE SUMMARY.

Handelsman Y, Bloomgarden ZT, Grunberger G, Umpierrez G, Zimmerman RS, Bailey TS, Blonde L, Bray GA, Cohen AJ, Dagogo-Jack S, Davidson JA, Einhorn D, Ganda OP, Garber AJ, Garvey WT, Henry RR, Hirsch IB, Horton ES, Hurley DL, Jellinger PS, Jovanovič L, Lebovitz HE, LeRoith D, Levy P, McGill JB, Mechanick JI, Mestman JH, Moghissi ES, Orzeck EA, Pessah-Pollack R, Rosenblit PD, Vinik AI, Wyne K, Zangeneh F.

Endocr Pract. 2015 Apr;21(4):413-37. No abstract available.

PMID:
27408942
41.

Effect of ruboxistaurin on albuminuria and estimated GFR in people with diabetic peripheral neuropathy: results from a randomized trial.

Tuttle KR, McGill JB, Bastyr EJ 3rd, Poi KK, Shahri N, Anderson PW.

Am J Kidney Dis. 2015 Apr;65(4):634-6. doi: 10.1053/j.ajkd.2014.11.024. Epub 2015 Jan 22. No abstract available.

PMID:
25618186
42.

Shoulder limited joint mobility in people with diabetes mellitus.

Shah KM, Ruth Clark B, McGill JB, Lang CE, Mueller MJ.

Clin Biomech (Bristol, Avon). 2015 Mar;30(3):308-13. doi: 10.1016/j.clinbiomech.2014.12.013. Epub 2015 Jan 6.

43.

Severe ovarian hyperstimulation syndrome in patients with autoimmune disorders: a report of two cases.

Kilpatrick CR, Ratts VS, Simckes E, McGill JB.

J Reprod Med. 2014 Nov-Dec;59(11-12):591-5.

PMID:
25552133
44.

Retinopathy and clinical outcomes in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia.

Bello NA, Pfeffer MA, Skali H, McGill JB, Rossert J, Olson KA, Weinrauch L, Cooper ME, de Zeeuw D, Rossing P, McMurray JJ, Solomon SD.

BMJ Open Diabetes Res Care. 2014 Apr 6;2(1):e000011. doi: 10.1136/bmjdrc-2013-000011. eCollection 2014.

45.

Upper extremity impairments, pain and disability in patients with diabetes mellitus.

Shah KM, Clark BR, McGill JB, Mueller MJ.

Physiotherapy. 2015 Jun;101(2):147-54. doi: 10.1016/j.physio.2014.07.003. Epub 2014 Sep 19.

46.

Safety and efficacy of hyperglycemia urgency order set.

Deal EN, Tobin GS, McGill JB.

J Diabetes Sci Technol. 2014 Sep;8(5):1062-3. doi: 10.1177/1932296814538236. Epub 2014 Jun 8. No abstract available.

47.

Anti-diabetes therapy: safety considerations for patients with impaired kidney function.

McGill JB.

Postgrad Med. 2014 May;126(3):161-71. doi: 10.3810/pgm.2014.05.2765. Review.

PMID:
24918801
48.

Prevention of inpatient hypoglycemia with a real-time informatics alert.

Kilpatrick CR, Elliott MB, Pratt E, Schafers SJ, Blackburn MC, Heard K, McGill JB, Thoelke M, Tobin GS.

J Hosp Med. 2014 Oct;9(10):621-6. doi: 10.1002/jhm.2221. Epub 2014 Jun 5.

PMID:
24898687
49.

The SGLT2 Inhibitor Empagliflozin for the Treatment of Type 2 Diabetes Mellitus: a Bench to Bedside Review.

McGill JB.

Diabetes Ther. 2014 Jun;5(1):43-63. doi: 10.1007/s13300-014-0063-1. Epub 2014 Apr 12.

50.

Effect of gender on treatment outcomes in type 2 diabetes mellitus.

McGill JB, Vlajnic A, Knutsen PG, Recklein C, Rimler M, Fisher SJ.

Diabetes Res Clin Pract. 2013 Dec;102(3):167-74. doi: 10.1016/j.diabres.2013.10.001. Epub 2013 Oct 8.

PMID:
24183259

Supplemental Content

Loading ...
Support Center